Stockreport

Kalaris and AlloVir Announce Stockholder Approval of Merger

AlloVir, Inc.  (ALVR) 
PDF PALO ALTO, Calif. and LEXINGTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Kalaris Therapeutics, Inc. (“Kalaris”), a clinical-stage biopharmaceutical company dedicated [Read more]